GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob / ob and high fat-fed mice
Do not use solution that has been reconstituted for more than 28 days, even if it appears clear
Fiber and Gut Health Support Some GLP-1 users experience constipation, while others may experience diarrhea or general digestive discomfort
A phase 3 programme evaluating retatrutide across multiple populations including adults with obesity, adults with type 2 diabetes, and individuals with obesity-related comorbidities is under way
Practical steps for day one: Keep a symptom diary from the outset Stay well hydrated throughout the day Avoid large, heavy, or high-fat meals immediately after your injection Have your healthcare team's and trial team's contact details readily available If you experience urgent or worsening symptoms, call NHS 111 for advice
Diabetes (2016) 65:171423